These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 18392239

  • 1. Angiotensin II type 1 receptor antagonist improves the prognosis in rats displaying liver cirrhosis induced by a choline-deficient diet.
    Iwata K, Sohda T, Irie M, Takeyama Y, Anan A, Shakado S, Sakisaka S.
    J Gastrointestin Liver Dis; 2008 Mar; 17(1):21-5. PubMed ID: 18392239
    [Abstract] [Full Text] [Related]

  • 2. Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis.
    Ibañez P, Solis N, Pizarro M, Aguayo G, Duarte I, Miquel JF, Accatino L, Arrese M.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):846-51. PubMed ID: 17565640
    [Abstract] [Full Text] [Related]

  • 3. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S, Takamura T, Ota T, Matsuzawa-Nagata N, Kita Y, Uno M, Nabemoto S, Ishikura K, Misu H, Ando H, Zen Y, Nakanuma Y, Kaneko S.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):316-24. PubMed ID: 18501344
    [Abstract] [Full Text] [Related]

  • 4. Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
    Kano S, Satoh K, Kaneta S, Ichihara K.
    Pharmacology; 2008 Jul 07; 82(1):22-9. PubMed ID: 18434761
    [Abstract] [Full Text] [Related]

  • 5. Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis.
    Nabeshima Y, Tazuma S, Kanno K, Hyogo H, Iwai M, Horiuchi M, Chayama K.
    Biochem Biophys Res Commun; 2006 Aug 04; 346(3):658-64. PubMed ID: 16774739
    [Abstract] [Full Text] [Related]

  • 6. Early lung injury contributes to lung fibrosis via AT1 receptor in rats.
    Chen FP, Gong LK, Zhang L, Wang H, Qi XM, Wu XF, Xiao Y, Cai Y, Liu LL, Li XH, Ren J.
    Acta Pharmacol Sin; 2007 Feb 04; 28(2):227-37. PubMed ID: 17241526
    [Abstract] [Full Text] [Related]

  • 7. Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor.
    Redondo-Müller MA, Stevanovic-Walker M, Barker S, Puddefoot JR, Vinson GP.
    Endocr Relat Cancer; 2008 Mar 04; 15(1):277-88. PubMed ID: 18310294
    [Abstract] [Full Text] [Related]

  • 8. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
    Kaji K, Yoshiji H, Kitade M, Ikenaka Y, Noguchi R, Shirai Y, Aihara Y, Namisaki T, Yoshii J, Yanase K, Tsujimoto T, Kawaratani H, Fukui H.
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun 04; 300(6):G1094-104. PubMed ID: 21372165
    [Abstract] [Full Text] [Related]

  • 9. Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation.
    Padrissa-Altés S, Franco-Gou R, Boillot O, Serafín A, Rimola A, Arroyo V, Rodés J, Peralta C, Roselló-Catafau J.
    Liver Transpl; 2009 Mar 04; 15(3):313-20. PubMed ID: 19242996
    [Abstract] [Full Text] [Related]

  • 10. Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor?
    van Esch JH, Oosterveer CR, Batenburg WW, van Veghel R, Jan Danser AH.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):286-93. PubMed ID: 18511032
    [Abstract] [Full Text] [Related]

  • 11. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G, Mohammadi-Karakani A, Sotoudeh M, Ghazi-Khansari M, Ghobadi G, Shakiba B.
    Biomed Pharmacother; 2008 Jun 07; 62(5):312-6. PubMed ID: 18191530
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of olive oil on fibrosis induced by carbon tetrachloride in rat liver.
    Fang HL, Lai JT, Lin WC.
    Clin Nutr; 2008 Dec 07; 27(6):900-7. PubMed ID: 18824281
    [Abstract] [Full Text] [Related]

  • 13. [Experimental study of saikosaponin-D (SSd) on lipid peroxidation of hepatic fibrosis on rat].
    He Y, Hu ZF, Li P, Xiao C, Chen YW, Li KM, Guo JZ, Pan L, Xiong JP.
    Zhongguo Zhong Yao Za Zhi; 2008 Apr 07; 33(8):915-9. PubMed ID: 18619352
    [Abstract] [Full Text] [Related]

  • 14. Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats.
    Tahan V, Atug O, Akin H, Eren F, Tahan G, Tarcin O, Uzun H, Ozdogan O, Tarcin O, Imeryuz N, Ozguner F, Celikel C, Avsar E, Tozun N.
    J Pineal Res; 2009 May 07; 46(4):401-7. PubMed ID: 19552763
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II type 2 receptor effect on microvascular hydraulic permeability.
    Newton CR, Curran B, Victorino GP.
    J Surg Res; 2004 Jul 07; 120(1):83-8. PubMed ID: 15172193
    [Abstract] [Full Text] [Related]

  • 16. Progression of lipid peroxidation measured as thiobarbituric acid reactive substances, damage to DNA and histopathological changes in the liver of rats subjected to a methionine-choline-deficient diet.
    Jordao AA, Zanutto ME, Domenici FA, Portari GV, Cecchi AO, Zucoloto S, Vannucchi H.
    Basic Clin Pharmacol Toxicol; 2009 Sep 07; 105(3):150-5. PubMed ID: 19594730
    [Abstract] [Full Text] [Related]

  • 17. Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?
    Ramalho FS, Alfany-Fernandez I, Casillas-Ramirez A, Massip-Salcedo M, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C.
    J Pharmacol Exp Ther; 2009 Apr 07; 329(1):130-40. PubMed ID: 19116369
    [Abstract] [Full Text] [Related]

  • 18. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
    Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Zhao JM, Yu J.
    Scand J Gastroenterol; 2009 Apr 07; 44(3):358-65. PubMed ID: 18991162
    [Abstract] [Full Text] [Related]

  • 19. Metabolites of the angiotensin II antagonist tasosartan: the importance of a second acidic group.
    Ellingboe JW, Collini MD, Quagliato D, Chen J, Antane M, Schmid J, Hartupee D, White V, Park CH, Tanikella T, Bagli JF.
    J Med Chem; 1998 Oct 22; 41(22):4251-60. PubMed ID: 9784100
    [Abstract] [Full Text] [Related]

  • 20. Distribution of the non-AT1, non-AT2 angiotensin-binding site in the rat brain: preliminary characterization.
    Karamyan VT, Speth RC.
    Neuroendocrinology; 2008 Oct 22; 88(4):256-65. PubMed ID: 18562784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.